Cours Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Actions
TEVA
IL0006290147
Produits pharmaceutiques
CA 2024 * | 15,86 Md 60,33 Md 14,44 Md | CA 2025 * | 16,35 Md 62,16 Md 14,88 Md | Capitalisation | 15,64 Md 59,48 Md 14,24 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 1,54 Md 5,85 Md 1,4 Md | Résultat net 2025 * | 1,44 Md 5,48 Md 1,31 Md | VE / CA 2024 * | 1,91 x |
Dette nette 2024 * | 14,62 Md 55,61 Md 13,31 Md | Dette nette 2025 * | 12,12 Md 46,08 Md 11,03 Md | VE / CA 2025 * | 1,7 x |
PER 2024 * |
11,1
x | PER 2025 * |
10,3
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 89,71% |
Dernier transcript sur Teva Pharmaceutical Industries Limited
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
+5,46% | 200 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md |